Aeterna Zentaris Inc. announced that the European Medicines Agency (EMA) has granted marketing authorization for Macrilen (macimorelin), an orally available...
FDA approves Macrilen for the diagnosis of patients with adult growth hormone deficiency.
Aeterna Zentaris Inc. has announced that the confirmatory Phase III clinical trial of Macrilen (macimorelin) failed to achieve its objective...
Novo Nordisk has announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights...
Aeterna Zentaris Inc. announced that, following a comprehensive review of data obtained from the confirmatory Phase III clinical trial of...
Aeterna Zentaris Inc. announced that it has been notified by the FDA, that the Company�s New Drug Application seeking approval...
Aeterna Zentaris has received a Complete Response Letter from the FDA for its New Drug Application for Macrilen (macimorelin), for...